MPG.eBooks - Search Results

1

CADTH Canadian Drug Expert Committee recommendation: Netupitant/palonosetron (Akynzeo -- Purdue Pharma) : indication : chemotherapy-induced nausea and vomiting

Published 2018

CADTH

Subjects: “...Nausea / drug therapy...”

Read Now

2

CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Combinations...”

Read Now

3

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Glaucoma / drug therapy...”

Read Now

4

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Glaucoma / drug therapy...”

Read Now

5

CADTH Canadian Drug Expert Committee final recommendation: Tiotropium/Olodaterol (Inspiolto Respimat - Boehringer Ingelheim Canada Ltd.) indication : chronic obstructive pulmonary...

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Combinations...”

Read Now

6

CADTH Canadian Drug Expert Committee recommendation: Travoprost 0.003% (Izba -- Novartis Pharmaceuticals Canada inc. on behalf of Alcon Canada Inc.) : indication : for the reductio...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ocular Hypertension / drug therapy...”

Read Now

7

CADTH Canadian Drug Expert Committee recommendation: Nitisinone (Orfadin -- Sobi Canada Inc.) : indication: the treatment of adult and pediatric patients with hereditary tyrosinemi...

Published 2018

CADTH

Subjects: “...Tyrosinemias / drug therapy...”

Read Now

8

CADTH Canadian Drug Expert Committee final recommendation: Propiverine hydrochloride (Mictoryl/Mictoryl Pediatric--Duchesnay Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Urinary Incontinence / drug therapy...”

Read Now

9

CADTH Canadian Drug Expert Committee final recommendation: Propiverine hydrochloride (Mictoryl/Mictoryl Pediatric--Duchesnay Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Urinary Incontinence / drug therapy...”

Read Now

10

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Asthma / drug therapy...”

Read Now

11

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Asthma / drug therapy...”

Read Now

12

CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Combinations...”

Read Now

13

CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Costs...”

Read Now

14

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

CADTH

Subjects: “...Drug Costs...”

Read Now

15

Pharmacoeconomic review report: Savuconazole (Cresemba) (AVIR pharma inc.)

Published 2019

CADTH

Subjects: “...Aspergillosis / drug therapy...”

Read Now

16

CADTH Canadian Drug Expert Committee recommendation: Isavuconazole (Cresemba -- Avir Pharma Inc.) : indication : for use in adults for the treatment of invasive aspergillosis, inva...

Published 2019

CADTH

Subjects: “...Aspergillosis / drug therapy...”

Read Now

17

CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Costs...”

Read Now

18

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Costs...”

Read Now

19

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Costs...”

Read Now

20

CADTH Canadian Drug Expert Committee recommendation: Nitisinone (MDK-Nitisinone -- mendeliKABs inc.) : indication : the treatment of adult and pediatric patients with hereditary ty...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Tyrosinemias / drug therapy...”

Narrow Search